Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

Health plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration ...

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...

Insurers also ask the Trump administration, which is engaged in a sweeping campaign to eradicate anything related to ...

A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...

The drugs identified for negotiation in the second round include: Ozempic, Wegovy and other GPL-inhibitors are in high demand in the U.S. Due to that demand, Medicare covering them for diabetes ...

If Robert F. Kennedy Jr. and the Trump administration want to make America healthy again, they should let Medicare cover ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.